http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1008842-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42331c425618dc75425f8ac9761ae035
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
filingDate 2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_145deecd2052d6c47e8b692b9a348b50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4472c224814c598b2d37e91ef8b4929f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07709f0c730d5891dd1c0749dfafbdcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b2a8be9f77d2502112d9890016b053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ccf2b0a1feeb190e9f00701a84c198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99215eb18a6a7b117919389f7ce221ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0db295e402fa1863dc2c0d65daba9a83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_375910cddc8f79a46eb12c79b7fb12df
publicationDate 2016-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GR-1008842-B
titleOfInvention PHARMACEUTICAL CONTAINER CONTAINING AN INFORMATIVE ANTI-REFRACTIVE FACTOR AND METHOD FOR PREPARING IT
abstract The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent, such as Paliperidone or a pharmaceutically acceptable salt thereof, in the form of a multilayer tablet, which provides a zero-order drug release. Also, the invention relates to the method of preparing said composition.
priorityDate 2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010022511-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009109993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013034605-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013064889-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010089775-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115237

Total number of triples: 35.